Supranormal expiratory airflow after bilateral lung transplantation is associated with improved survival

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 1, 2011, Pages 79-87

  Eberlein, Michael ^a,b   Permutt, Solbert ^a   Brown, Robert H ^a   Brooker, Allison ^a   Chahla, Mayy F ^a   Bolukbas, Servet ^c   Nathan, Steven D ^d   Pearse, David B ^a   Orens, Jonathan B ^a   Brower, Roy G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

^d INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Dysanapsis; Flow volume loops; Lung size mismatch; Lung transplantation; Surface tension

Indexed keywords

ADULT; AIRWAY RESISTANCE; ARTICLE; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; LUNG COMPLIANCE; LUNG FLOW VOLUME CURVE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; RESPIRATORY AIRFLOW; RETROSPECTIVE STUDY; SURVIVAL RATE; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; BRONCHIOLITIS OBLITERANS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SPIROMETRY; SURVIVAL RATE; UNITED STATES;

EID: 78650770860     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201004-0593OC     Document Type: Article

References (38)

1. Miller DR, Hyatt RE. Obstructive lesions of the larynx and trachea. Mayo Clin Proc 1969;44:145-161.
2. Miller DR, Hyatt RE. Evaluating obstructive lesions of the larynx and trachea by flow volume loops. Am Rev Respir Dis 1973;108:475-481.
3. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-968.
4. Theodore J, Jamieson SW, Burke CM, Reitz BA, Stinson EB, Van Kessel A, Dawkins KD, Herran JJ, Oyer PE, Hunt SA. Physiologic aspects of human heart-lung transplantation pulmonary function status of the post-transplanted lung. Chest 1984;86:349-357. (Pubitemid 14027346)
5. Estenne M, Ketelbant P, Primo G, Yernault JC. Human heart-lung transplantation: physiologic aspects of the denervated lung and post-transplant obliterative bronchiolitis. Am Rev Respir Dis 1987;135:976-978. (Pubitemid 17055533)
6. Pride NB, Permutt S, Riley RL, Bromberger-Barnea B. Determinants of maximal expiratory flow from the lungs. J Appl Physiol 1967;23:646-662.
7. Eberlein M, Permutt S, Brown RH, Chahla M, Bolukbas S, Orens JB, Brower RG. The pseudo-variable extrathoracic obstruction flow volume loop pattern in double lung and heart lung transplantation. Am J Respir Crit Care Med 2010;181:A2188.
8. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
9. Permutt S, Menkes HA. Spirometry. Analysis of forced expiration within the time domain. In: Macklem PT, Permutt S, editors. Lung biology in health and disease. Vol 12. The lung in the transition between health and disease. New York: Dekker; 1979. pp. 113-152.
10. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J 1995;8:492-506.
11. Amirav I, Kramer SS, Grunstein MM, Hoffman EA. Assessment of methacholine-induced airway constriction by ultrafast high-resolution computed tomography. J Appl Physiol 1993;75:2239-2250. (Pubitemid 23352402)
12. Brown RH, Zerhouni EA, Mitzner W. Visualization of airway obstruction in vivo during lung vascular engorgement and edema. J Appl Physiol 1995;78:1070-1078.
13. Green M, Mead J, Turner JM. Variability of maximum expiratory flow-volume curves. J Appl Physiol 1974;37:67-74.
14. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. Am J Respir Crit Care Med 1998;157:715-722. (Pubitemid 28150678)
15. Lloyd KS, Barnard P, Holland VA, Noon GP, Lawrence EC. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis 1990;142:1026-1029. (Pubitemid 20384354)
16. Leith DE, Mead J. Mechanisms determining residual volume of the lungs in normal subjects. J Appl Physiol 1967;23:221-227.
17. Mead J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 1980;121:339-342. (Pubitemid 10095228)
18. Brown RH, Pearse DB, Pyrgos G, Liu MC, Togias A, Permutt S. The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol 2006;101:30-39.
19. Reid DW, Walters EH, Johns DP, Ward C, Burns GP, Liakakos P, Williams TJ, Snell GI. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2005;24:489-492.
20. Bachofen H, Schürch S, Urbinelli M, Weibel ER. Relations among alveolar surface tension, surface area, volume, and recoil pressure. J Appl Physiol 1987;62:1878-1887.
21. Butler J, Caro CG, Alcala R, Dubois AB. Some effects of restriction of chest cage expansion on pulmonary function in man: an experimental study. J Clin Invest 1960;39:584-591.
22. Stubbs SE, Hyatt RE. Effect of increased lung recoil pressure on maximal expiratory flow in normal subjects. J Appl Physiol 1972;32:325-331.
23. Douglas NJ, Drummond GB, Sudlow MF. Breathing at low lung volumes and chest strapping: a comparison of mechanisms. J Appl Physiol 1981;50:650-657.
24. Faridy EE, Permutt S, Riley RL. Effect of ventilation on surface forces in excised dogs' lungs. J Appl Physiol 1966;21:1453-1462.
25. Estenne M, Gevenois PA, Kinnear W, Soudon P, Heilporn A, De Troyer A. Lung volume restriction in patients with chronic respiratory muscle weakness: the role of microatelectasis. Thorax 1993l;48:698-701.
26. Chacon RA, Corris PA, Dark JH, Gibson GJ. Respiratory mechanics after heart-lung and bilateral lung transplantation. Thorax 1997;52:718-722.
27. Estenne M, Yernault JC, De Troyer A. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med 1983;74:813-819.
28. McDyer JF. Human and murine obliterative bronchiolitis in transplant. Proc Am Thorac Soc 2007;4:37-43.
29. Hohlfeld JM, Tiryaki E, Hamm H, Hoymann HG, Krug N, Haverich A, Fabel H. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 1998;158:706-712. (Pubitemid 28449430)
30. Meloni F, Salvini R, Bardoni AM, Passadore I, Solari N, Vitulo P, Oggionni T, Viganò M, Pozzi E, Fietta AM. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset. J Heart Lung Transplant 2007;26:1135-1143. (Pubitemid 350088520)
31. Inselman LS, Chander A, Spitzer AR. Diminished lung compliance and elevated surfactant lipids and proteins in nutritionally obese young rats. Lung 2004;182:101-117. (Pubitemid 38543708)
32. Dixon DL, De Pasquale CG, De Smet HR, Klebe S, Orgeig S, Bersten AD. Reduced surface tension normalizes static lung mechanics in a rodent chronic heart failure model. Am J Respir Crit Care Med 2009;180:181-187.
33. Egan TM, Thompson JT, Detterbeck FC, Lackner RP, Mill MR, Ogden WD, Aris RM, Paradowski LJ. Effect of size (mis)matching in clinical double-lung transplantation. Transplantation 1995;15:707-713.
34. Otulana BA, Mist BA, Scott JP, Wallwork J, Higenbottam T. The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation 1989;48:625-629.
35. Mason DP, Batizy LH, Wu J, Nowicki ER, Murthy SC, McNeill AM, Budev MM, Mehta AC, Pettersson GB, Blackstone EH. Matching donor to recipient in lung transplantation: how much does size matter? J Thorac Cardiovasc Surg 2009;137:1234-1240.
36. Ganesh JS, Rogers CA, Banner NR, Bonser RS. Donor cause of death and mid-term survival in lung transplantation. J Heart Lung Transplant 2005;24:1544-1549.
37. Erasmus ME, Hofstede GJ, Petersen AH, Haagsman HP, Oetomo SB, Prop J. Effects of early surfactant treatment persisting for one week after lung transplantation in rats. Am J Respir Crit Care Med 1997;156:567-572.
38. Strüber M, Fischer S, Niedermeyer J, Warnecke G, Gohrbandt B, Görler A, Simon AR, Haverich A, Hohlfeld JM. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 2007;133:1620-1625.